中文
We are committed to developing safe and effective innovative drugs to combat the serious threats posed by cancer and autoimmune diseases
With well-established R&D and commercialization capabilities, InnoCare is dedicated to addressing
the huge unmet medical needs in the field of cancer and autoimmune diseases, by discovering and
developing first-in-class or best-in-class drugs globally.
the huge unmet medical needs in the field of cancer and autoimmune diseases, by discovering and
developing first-in-class or best-in-class drugs globally.
Dual A+H Listing
Three Marketed Products
Pipelines in
Clinical Stage
Clinical Stage
Clinical
Trials
Trials
Patents and Patent
Applications
Applications
Innovative Pipeline
Spotlight
InnoCare 2026 Interim Results Snapshot
m
Revenue
m
Profit
m
Cash and Related Accounts Balance
Jasmine Cui, Ph.D.
Co-founder, Chairwoman and CEO, InnoCare
“We will continue to achieve fast growth in commercialization, accelerate innovation and global expansion to benefit patients worldwide!”
News
Subscription for Investor
To stay up-to-date with the latest information from InnoCare,
please subscribe to our investor newsletter
and select the categories to receive news and other information by email.
please subscribe to our investor newsletter
and select the categories to receive news and other information by email.
